1. Lai, CC, Shih, TP, Ko, WC, Tang, HJ, Hsueh, PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924.
Google Scholar | Crossref | Medline2. Chen, F, Liu, ZS, Zhang, FR, et al. [First case of severe childhood novel coronavirus pneumonia in China]. Zhonghua Er Ke Za Zhi. 2020;58:179-182.
Google Scholar | Medline3. Helms, J, Tacquard, C, Severac, F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089-1098.
Google Scholar | Crossref | Medline4. Magro, C, Mulvey, JJ, Berlin, D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1-13.
Google Scholar | Crossref | Medline5. Fox, S, Akmatbekov, A, Harbert, J, Li, G, Quincy Brown, J, Vander Heide, R. Pulmonary and cardiac pathology in covid-19: The first autopsy series from New Orleans. MedRxiv (preprint, not peer-reviewed). 2020.
Google Scholar6. Merrill, JT, Erkan, D, Winakur, J, James, JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16:581-589.
Google Scholar | Crossref | Medline7. Su, H, Yang, M, Wan, C, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98:219-227.
Google Scholar | Crossref | Medline8. Menter, T, Haslbauer, JD, Nienhold, R, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198-209.
Google Scholar | Crossref | Medline9. Gavriilaki, E, Brodsky, RA. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020;189:e227-e230.
Google Scholar | Crossref | Medline10. Lopes da Silva, R . Viral-associated thrombotic micro-angiopathies. Hematol Oncol Stem Cell Ther. 2011;4:51-59.
Google Scholar | Crossref | Medline11. Allen, U, Licht, C. Pandemic H1N1 influenza A infection and (atypical) HUS-more than just another trigger? Pediatr Nephrol. 2011;26:3-5.
Google Scholar | Crossref | Medline12. Bitzan, M, Zieg, J. Influenza-associated thrombotic microangiopathies. Pediatr Nephrol. 2018;33:2009-2025.
Google Scholar | Crossref | Medline13. Lopez, C, Kim, J, Pandey, A, Huang, T, DeLoughery, TG. Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia. Br J Haematol. 2020;190:31-32.
Google Scholar | Crossref | Medline14. Alizadeh, F, O’Halloran, A, Alghamdi, A, et al. Toddler with new onset diabetes and atypical hemolytic-uremic syndrome in the setting of COVID-19. Pediatrics. 2021;147:e2020016774.
Google Scholar | Crossref | Medline15. Ville, S, Le Bot, S, Chapelet-Debout, A, et al. Atypical HUS relapse triggered by COVID-19. Kidney Int. 2021;99:267-268.
Google Scholar | Crossref | Medline16. Tang, N, Bai, H, Chen, X, Gong, J, Li, D, Sun, Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18:1094-1099.
Google Scholar | Crossref | Medline17. Gao, T, Hu, M, Zhang, X, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv. 2020. doi:10.1101/2020.03.29.20041962
Google Scholar | Crossref18. Balagholi, S, Dabbaghi, R, Eshghi, P, Mousavi, SA, Heshmati, F, Mohammadi, S. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: immunopathogenesis and coagulopathy. Transfus Apher Sci. 2020;59:102993.
Google Scholar | Crossref | Medline19. Diurno, F, Numis, FG, Porta, G, et al. Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci. 2020;24:4040-4047.
Google Scholar | Medline20. Laurence, J, Mulvey, JJ, Seshadri, M, et al. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clin Immunol. 2020;219:108555.
Google Scholar | Crossref | Medline